Studies Open for Enrollment

CP-AI-007: A Phase 3, Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysinate for Inhalation in Cystic Fibrosis Patients with Pulmonary P. aeruginosa (AIR-CF1)

Those with Cystic Fibrosis (CF) often have lung infections that occur repeatedly or worsen over time. Research has shown that inhaling an antibiotic as a mist is an effective way to treat lung infections in CF. The purpose of this research study is to test an experimental drug called aztreonam lysinate for inhalation.

Compensation provided. All study-related evaluations, study medication, and supplies will be free of charge.

Candidates

• Patients with cystic fibrosis and 6 years of age and older, Pseudomonas aeruginosa in the sputum

Requirements

• This study requires physical exams, PFTs, and blood tests.

Visits: 5

Duration: about 2 months

Status: Open for Enrollment

How to Participate
If you are interested in seeing if you/your child is eligible for participation in this study and/or would like to hear more about the study, please call Liz at 412-692-7060 or Sandy at 412-692-7042.

Top Updated 11/30/07